Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
Clinical trial NCT02858895 · COMPLETED
Trial details
- NCT number
- NCT02858895
- Sponsor
- Medicenna Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-11
- Primary completion
- 2019-09-12
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.